EMILY SCAVELLA: Open Payments
NPI 1124278304 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,638 in 190 payments from 31 companies in 2025. Trend: 2023 $2,934 · 2024 $2,736 · 2025 $2,638
Food & beverage: $2,634Education: $4
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $420 |
| Dexcom, Inc. | 57 | $420 |
| Madrigal Pharmaceuticals | 23 | $189 |
| Corcept Therapeutics | 14 | $174 |
| Amneal Pharmaceuticals LLC | 9 | $157 |
| Lilly USA, LLC | 9 | $128 |
| Antares Pharma, Inc. | 6 | $113 |
| CeQur Corporation | 1 | $96 |
| Tandem Diabetes Care, Inc. | 11 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
Products named: Dexcom G6 Transmitter, Wegovy, REZDIFFRA, Korlym, UNITHROID, JARDIANCE, XYOSTED, CeQur Simplicity.
Industry payments across PA — which companies pay providers there.
